Hepatitis A and typhoid vaccine
Appearance
(Redirected from ViATIM)
Combination of | |
---|---|
Hepatitis A | Vaccine |
Typhoid | Vaccine |
Clinical data | |
Trade names | ViVaxim, Hepatyrix, ViATIM |
AHFS/Drugs.com | UK Drug Information |
Pregnancy category |
|
Routes of administration | Intramuscular injection |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
Hepatitis A and typhoid vaccine is a combination vaccine to protect against the infectious diseases hepatitis A and typhoid. It is a combination of inactivated Hepatitis A virus and Vi polysaccharide of Salmonella typhi bacteria. Branded formulations include Hepatyrix from GlaxoSmithKline,[1][2] and ViVaxim[3][4][5][6][7] and ViATIM[8] from Sanofi Pasteur.[1][9]
Society and culture
[edit]Brand names
[edit]The vaccine is distributed under various brand names in the European Union.[1]
References
[edit]- ^ a b c List of nationally authorised medicinal products. Active substance(s): hepatitis a (inactivated) / typhoid polysaccharide vaccine (adsorbed) (PDF) (Report). European Medicines Agency (EMA). Retrieved 18 October 2020.
- ^ "Hepatyrix. Package Leaflet:Information for the user" (PDF). Drugs.com. Archived from the original (PDF) on 15 July 2018. Retrieved 15 July 2018.
- ^ "VIVAXIM suspension and solution for suspension for injection in pre-filled syringe". Drugs.com. Archived from the original on 15 July 2018. Retrieved 15 July 2018.
- ^ "Australian Product Information – Vivaxim (Salmonella typhi Vi polysaccharide and hepatitis A virus antigen) Vaccine" (PDF). Retrieved 18 October 2020.
- ^ "Vivaxim Salmonella typhi vaccine; Hepatitis A vaccine". Retrieved 18 October 2020.
- ^ "Vivaxim 1mL injection syringe composite pack". Therapeutic Goods Administration (TGA). Archived from the original on 19 October 2020. Retrieved 18 October 2020.
- ^ "Summary for ARTG Entry: 82745 Vivaxim 1mL injection syringe composite pack" (PDF). Therapeutic Goods Administration (TGA). Retrieved 18 October 2020.[permanent dead link]
- ^ "ViATIM suspension and solution for suspension for injection in pre-filled syringe". Drugs.com. Archived from the original on 15 July 2018. Retrieved 15 July 2018.
- ^ "ViATIM suspension and solution for suspension for injection in pre-filled syringe - Summary of Product Characteristics (SmPC)". (emc). 3 September 2019. Retrieved 18 October 2020.